Enoxolone Other names: Glycyrrhetic acid Glycyrrhetinic acid

Chemical formula: C₃₀H₄₆O₄  Molecular mass: 470.694 g/mol  PubChem compound: 10114

Active ingredient description

Enoxolone is a pentacyclic triterpenoid aglycone metabolite of glycyrrhizin, which is a product of the plant Glycyrrhiza glabra (licorice), with potential expectorant, and gastrokinetic activities. After administration, enoxolone inhibits the metabolism of prostaglandins by both 15-hydroxyprostaglandin dehydrogenase [NAD] and prostaglandin reductase 2.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
D03AX10 Enoxolone D Dermatologicals → D03 Preparations for treatment of wounds and ulcers → D03A Cicatrizants → D03AX Other cicatrizants
Discover more medicines within D03AX10

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 471-53-4
DrugBank Drug: DB13089
PubChem Compound: 10114
RxNorm Ingredient: 1311506
SNOMED-CT Concept: 414357000
Enoxolone (substance)
UNII Identifier: P540XA09DR
ENOXOLONE

Medicines

Enoxolone is an active ingredient of these brands:

Hong Kong (HK)

Japan (JP)

Lithuania (LT)

Mexico (MX)

Singapore (SG)

  • (combination) VETIC as Glycyrrhetinic acid

Spain (ES)

Turkey (TR)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.